The Women TDF-FTC Benchmark Study
NCT05057858
·
clinicaltrials.gov ↗
PHASE2
Phase
ACTIVE_NOT_RECRUITING
Status
72
Enrollment
OTHER
Sponsor class
Conditions
HIV Infections
Interventions
DRUG:
co-formulated 300 mg TDF/ 200mg FTC
Sponsor
University of Washington
Collaborators
[object Object]
[object Object]
[object Object]